MedTrace Logo

Medrol Dose Packs for Post-Operative Pain Control

NCT06453083 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2025-01-07

No results posted yet for this study

Summary

The investigators primary purpose of this study is to determine if the addition of a short course use of steroids following surgery for Adolescent Idiopathic Scoliosis (AIS) will improve post-operative pain management and shorten hospital length of stay.

Conditions

Interventions

DRUG

Placebo

Placebo tablets will be dispensed to the participants for 6-days.

DRUG

Medrol

Medrol tablets will be dispensed to the participants for 6-days.

Sponsors & Collaborators

Principal Investigators

  • Joshua Klatt, M.D. · University of Utah Orthopaedics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-13
Primary Completion
2024-12-17
Completion
2024-12-17
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06453083 on ClinicalTrials.gov